FDA authorizes use of bivalent mRNA COVID-19 vaccines, monovalent rescinded
SILVER SPRING, MD, April 18, 2023—The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the
Read moreSILVER SPRING, MD, April 18, 2023—The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the
Read more